Constellation Brands, Inc. (STZ) stock
Close on Oct 30, 2026Market cap $23.11BP/E –Yield –
Earnings
Constellation Brands's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.
Quarterly results
Revenue and earnings per share from each of Constellation Brands's earnings releases, newest first
| Quarter | Reported | Revenue | YoY | EPS | Adj. EPS | Source |
|---|---|---|---|---|---|---|
| Q3 FY2027ended Nov 30, 2026 | Jan 6, 2027Expected | – | – | – | – | – |
| Q2 FY2027ended Aug 31, 2026 | Oct 6, 2026after the close | – | – | $3.32 | $3.74 | Release |
| Q1 FY2027ended May 31, 2026 | Jun 30, 2026after the close | $2.43B | -3.3% | $3.79 | $3.43 | Release |
| Q4 FY2026ended Feb 28, 2026 | Apr 8, 2026after the close | – | – | – | – | Release |
| Q3 FY2026ended Nov 30, 2025 | Jan 7, 2026after the close | $2.22B | -9.8% | $2.88 | $3.06 | Release |
| Q2 FY2026ended Aug 31, 2025 | Sep 2, 2025before the open | – | – | – | – | Release |
| Q1 FY2026ended May 31, 2025 | Jul 1, 2025after the close | $2.52B | -5.5% | $2.90 | $3.22 | Release |
| Q4 FY2025ended Feb 28, 2025 | Apr 9, 2025after the close | – | – | – | – | Release |
| Q3 FY2025ended Nov 30, 2024 | Jan 10, 2025before the open | $2.46B | -0.3% | $3.39 | $3.25 | Release |
| Q2 FY2025ended Aug 31, 2024 | Sep 3, 2024before the open | – | – | – | – | Release |
| Q1 FY2025ended May 31, 2024 | Jul 3, 2024before the open | $2.66B | +5.8% | $4.78 | $3.57 | Release |
| Q4 FY2024ended Feb 29, 2024 | Apr 11, 2024before the open | $2.14B | +7.1% | $2.14 | $2.26 | Release |
| Q3 FY2024ended Nov 30, 2023 | Jan 5, 2024before the open | $2.47B | +1.4% | $2.76 | $3.19 | Release |
| Q2 FY2024ended Aug 31, 2023 | Oct 5, 2023before the open | $2.84B | +6.8% | $3.74 | $3.70 | Release |
| Q1 FY2024ended May 31, 2023 | Jun 30, 2023before the open | $2.51B | – | $0.74 | $2.91 | Release |
| Q4 FY2023ended Feb 28, 2023 | Apr 6, 2023before the open | $2.00B | -5.0% | $1.21 | $1.98 | Release |
| Q3 FY2023ended Nov 30, 2022 | Jan 5, 2023before the open | $2.44B | +5.0% | $2.52 | $2.83 | Release |
| Q2 FY2023ended Aug 31, 2022 | Oct 6, 2022before the open | $2.66B | – | -$6.30 | $3.17 | Release |
| Q1 FY2023ended May 31, 2022 | Jun 13, 2022after the close | – | – | – | – | Filing |
| Q4 FY2022ended Feb 28, 2022 | Apr 7, 2022before the open | $2.10B | – | $2.07 | $2.37 | Release |
| Q3 FY2022ended Nov 30, 2021 | Jan 6, 2022before the open | $2.32B | – | $2.48 | $3.12 | Release |
| Q2 FY2022ended Aug 31, 2021 | Oct 6, 2021before the open | – | – | – | – | Release |
| Q1 FY2022ended May 31, 2021 | Jun 3, 2021after the close | – | – | – | – | Filing |
| Q4 FY2021ended Feb 28, 2021 | Apr 8, 2021before the open | – | – | – | – | Release |
| Q3 FY2021ended Nov 30, 2020 | Jan 7, 2021before the open | – | – | – | – | Release |
| Q2 FY2021ended Aug 31, 2020 | Oct 1, 2020before the open | – | – | – | – | Release |
Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.
Current guidance
Constellation Brands's latest outlook for periods it has not reported yet, compared with what it said before
| Metric | Period | Guidance | Before | Change | Given |
|---|---|---|---|---|---|
| Net sales (GAAP)GAAP | FY2027 | $8.91B – $9.09B | – | New | Jun 30, 2026 |
| organic net sales growth (decline)non-GAAP | FY2027 | -1% – +1% | -1% – +1% | Reaffirmed | Oct 6, 2026 |
| Comparable operating income (Non-GAAP)non-GAAP | FY2027 | $2.84B – $2.99B | – | New | Jun 30, 2026 |
| Operating income (GAAP)GAAP | FY2027 | $2.83B – $2.98B | – | New | Jun 30, 2026 |
| comparable Enterprise operating marginnon-GAAP | FY2027 | 32% – 33% | 32% – 33% | Reaffirmed | Oct 6, 2026 |
| reported Enterprise operating marginGAAP | FY2027 | 31% – 32% | 32% – 33% | Lowered | Oct 6, 2026 |
| Forecasted EPS (GAAP)GAAP | FY2027 | $11.85 – $12.55 | $11.50 – $12.20 | Raised | Oct 6, 2026 |
| comparable EPS outlooknon-GAAP | FY2027 | $11.20 – $11.90 | $11.20 – $11.90 | Reaffirmed | Oct 6, 2026 |
| free cash flownon-GAAP | FY2027 | $1.60B – $1.70B | $1.60B – $1.70B | Reaffirmed | Oct 6, 2026 |
| Capital expenditures | FY2027 | $800.00M | $800.00M | Reaffirmed | Oct 6, 2026 |
| Net cash provided by operating activities (GAAP)GAAP | FY2027 | $2.40B – $2.50B | – | Reaffirmed | Jun 30, 2026 |
| operating cash flowGAAP | FY2027 | $2.40B – $2.50B | – | Reaffirmed | Oct 6, 2026 |
| operating cash flow targetGAAP | FY2027 | $2.40B – $2.50B | – | New | Apr 8, 2026 |
| Tax rate: comparablenon-GAAP | FY2027 | 20% | – | New | Oct 6, 2026 |
| Tax rate: reportedGAAP | FY2027 | 12% | – | New | Oct 6, 2026 |
| Tax rate: reported and comparable | FY2027 | 20% | – | New | Apr 8, 2026 |
Guidance history
Every forecast Constellation Brands put in an earnings release, newest first
| Given | Metric | Period | Guidance | Change |
|---|---|---|---|---|
| Oct 6, 2026 | Capital expenditures | FY2027 | $800.00M | Reaffirmed |
| Oct 6, 2026 | comparable EPS outlook | FY2027 | $11.20 – $11.90 | Reaffirmed |
| Oct 6, 2026 | Forecasted EPS (GAAP) | FY2027 | $11.85 – $12.55 | Raised |
| Oct 6, 2026 | free cash flow | FY2027 | $1.60B – $1.70B | Reaffirmed |
| Oct 6, 2026 | reported Enterprise operating margin | FY2027 | 31% – 32% | Lowered |
| Oct 6, 2026 | comparable Enterprise operating margin | FY2027 | 32% – 33% | Reaffirmed |
| Oct 6, 2026 | Tax rate: reported | FY2027 | 12% | New |
| Oct 6, 2026 | Tax rate: comparable | FY2027 | 20% | New |
| Oct 6, 2026 | operating cash flow | FY2027 | $2.40B – $2.50B | Reaffirmed |
| Oct 6, 2026 | organic net sales growth (decline) | FY2027 | -1% – +1% | Reaffirmed |
| Jun 30, 2026 | Purchase of property, plant, and equipment | FY2027 | $800.00M | Reaffirmed |
| Jun 30, 2026 | Forecasted comparable EPS (Non-GAAP) | FY2027 | $11.20 – $11.90 | Reaffirmed |
| Jun 30, 2026 | Forecasted EPS (GAAP) | FY2027 | $11.50 – $12.20 | Raised |
| Jun 30, 2026 | Free cash flow (Non-GAAP) | FY2027 | $1.60B – $1.70B | Reaffirmed |
| Jun 30, 2026 | Operating income (GAAP) | FY2027 | $2.83B – $2.98B | New |
| Jun 30, 2026 | Comparable operating income (Non-GAAP) | FY2027 | $2.84B – $2.99B | New |
| Jun 30, 2026 | Operating margin (GAAP) | FY2027 | 32% – 33% | New |
| Jun 30, 2026 | Comparable operating margin (Non-GAAP) | FY2027 | 32% – 33% | New |
| Jun 30, 2026 | Net cash provided by operating activities (GAAP) | FY2027 | $2.40B – $2.50B | Reaffirmed |
| Jun 30, 2026 | organic net sales growth (decline) | FY2027 | -1% – +1% | Reaffirmed |
| Jun 30, 2026 | Net sales (GAAP) | FY2027 | $8.91B – $9.09B | New |
| Apr 8, 2026 | Capital expenditures | FY2027 | $800.00M | New |
| Apr 8, 2026 | comparable EPS outlook | FY2027 | $11.20 – $11.90 | New |
| Apr 8, 2026 | Forecasted EPS (GAAP) | FY2027 | $11.10 – $11.80 | New |
| Apr 8, 2026 | free cash flow target | FY2027 | $1.60B – $1.70B | New |
| Apr 8, 2026 | Tax rate: reported and comparable | FY2027 | 20% | New |
| Apr 8, 2026 | operating cash flow target | FY2027 | $2.40B – $2.50B | New |
| Apr 8, 2026 | Enterprise organic net sales growth (decline) | FY2027 | -1% – +1% | New |
| Jan 7, 2026 | Capital expenditures | FY2026 | $1.20B | Reaffirmed |
| Jan 7, 2026 | comparable EPS | FY2026 | $11.30 – $11.60 | Lowered |
| Jan 7, 2026 | reported EPS | FY2026 | $9.72 – $10.02 | Lowered |
| Jan 7, 2026 | Free cash flow | FY2026 | $1.30B – $1.40B | Lowered |
| Jan 7, 2026 | operating income growth (decline): reported | FY2026 | +657% – +677% | Lowered |
| Jan 7, 2026 | operating income growth (decline): comparable | FY2026 | -11% – -9% | Lowered |
| Jan 7, 2026 | Operating cash flow | FY2026 | $2.50B – $2.60B | New |
| Jan 7, 2026 | organic net sales | FY2026 | -6% – -4% | Lowered |
| Jul 1, 2025 | Capital expenditures | FY2026 | $1.20B | Reaffirmed |
| Jul 1, 2025 | comparable EPS | FY2026 | $12.60 – $12.90 | Reaffirmed |
| Jul 1, 2025 | reported EPS | FY2026 | $12.07 – $12.37 | Lowered |
| Jul 1, 2025 | free cash flow | FY2026 | $1.50B – $1.60B | Reaffirmed |
| Jul 1, 2025 | operating income growth (decline): reported | FY2026 | +742% – +760% | Lowered |
| Jul 1, 2025 | operating income growth (decline): comparable | FY2026 | -3% – -1% | Reaffirmed |
| Jul 1, 2025 | Interest expense, net | FY2026 | $385.00M | Raised |
| Jul 1, 2025 | Weighted average diluted shares outstanding | FY2026 | 176 | New |
| Jul 1, 2025 | Tax rate: reported | FY2026 | 15% | New |
| Jul 1, 2025 | Tax rate: comparable | FY2026 | 18% | New |
| Jul 1, 2025 | operating cash flow | FY2026 | $2.70B – $2.80B | New |
| Jul 1, 2025 | Corporate expense | FY2026 | $265.00M | Lowered |
| Jul 1, 2025 | organic net sales growth (decline) | FY2026 | -2% – +1% | Raised |
| Apr 9, 2025 | Capital expenditures | FY2026 | $1.20B | New |
| Apr 9, 2025 | comparable EPS outlook | FY2026 | $12.60 – $12.90 | New |
| Apr 9, 2025 | reported EPS outlook | FY2026 | $12.33 – $12.63 | New |
| Apr 9, 2025 | free cash flow projection | FY2026 | $1.50B – $1.60B | New |
| Apr 9, 2025 | Beer: operating income growth | FY2026 | 0% – +2% | New |
| Apr 9, 2025 | Wine and Spirits: operating income decline | FY2026 | -100% – -97% | Lowered |
| Apr 9, 2025 | Enterprise operating income growth (decline): reported | FY2026 | +765% – +783% | New |
| Apr 9, 2025 | Enterprise operating income growth (decline): comparable | FY2026 | -3% – -1% | New |
| Apr 9, 2025 | Beer: net sales growth | FY2026 | 0% – +3% | New |
| Apr 9, 2025 | Enterprise organic net sales growth (decline) | FY2026 | -2% – +1% | New |
| Apr 9, 2025 | Wine and Spirits: organic net sales decline | FY2026 | -20% – -17% | Lowered |
| Jan 10, 2025 | capital expenditures | fiscal 2025 to fiscal 2028 | $3.00B | – |
| Jan 10, 2025 | Capital expenditures | FY2025 | $1.30B | New |
| Jan 10, 2025 | comparable EPS | FY2025 | $13.40 – $13.80 | New |
| Jan 10, 2025 | reported EPS | FY2025 | $3.90 – $4.30 | New |
| Jan 10, 2025 | free cash flow projection | FY2025 | $1.60B – $1.80B | New |
| Jan 10, 2025 | operating income growth (decline): comparable | FY2025 | +6% – +9% | New |
| Jan 10, 2025 | operating income growth outlook | FY2025 | +9% – +12% | New |
| Jan 10, 2025 | operating income decline | FY2025 | -19% – -17% | Lowered |
| Jan 10, 2025 | operating income growth (decline): reported | FY2025 | -65% – -62% | New |
| Jan 10, 2025 | Tax rate: reported | FY2025 | 8% | New |
| Jan 10, 2025 | Weighted average diluted shares outstanding | FY2025 | 182.5 | New |
| Jan 10, 2025 | Tax rate: comparable | FY2025 | 18.5% | New |
| Jan 10, 2025 | Corporate expense | FY2025 | $250.00M | New |
| Jan 10, 2025 | Interest expense, net | FY2025 | $410.00M | Raised |
| Jan 10, 2025 | operating cash flow target | FY2025 | $2.90B – $3.10B | New |
| Jan 10, 2025 | net sales growth | FY2025 | +4% – +7% | New |
| Jan 10, 2025 | organic net sales growth | FY2025 | +2% – +5% | New |
| Jan 10, 2025 | organic net sales decline | FY2025 | -8% – -5% | Lowered |
| Sep 3, 2024 | Capital expenditures | FY2025 | $1.40B – $1.50B | Reaffirmed |
| Sep 3, 2024 | comparable EPS | FY2025 | $13.60 – $13.80 | Raised |
| Sep 3, 2024 | reported EPS | FY2025 | $3.05 – $7.92 | Lowered |
| Sep 3, 2024 | Free cash flow | FY2025 | $1.40B – $1.50B | Reaffirmed |
| Sep 3, 2024 | reported operating income decline | FY2025 | -68% – -36% | Lowered |
| Sep 3, 2024 | comparable operating income growth | FY2025 | +8% – +9% | Lowered |
| Sep 3, 2024 | Enterprise net sales growth | FY2025 | +4% – +6% | Lowered |
| Jul 3, 2024 | Capital expenditures | FY2025 | $1.40B – $1.50B | Reaffirmed |
| Jul 3, 2024 | comparable EPS outlook | FY2025 | $13.50 – $13.80 | Reaffirmed |
| Jul 3, 2024 | reported EPS outlook | FY2025 | $14.63 – $14.93 | Raised |
| Jul 3, 2024 | Free cash flow | FY2025 | $1.40B – $1.50B | Reaffirmed |
| Jul 3, 2024 | operating income growth: reported | FY2025 | +10% – +12% | Reaffirmed |
| Jul 3, 2024 | operating income growth: comparable | FY2025 | +8% – +10% | Reaffirmed |
| Jul 3, 2024 | net sales growth | FY2025 | +6% – +7% | Reaffirmed |
| Apr 11, 2024 | Capital expenditures | FY2025 | $1.40B – $1.50B | New |
| Apr 11, 2024 | comparable EPS | FY2025 | $13.50 – $13.80 | New |
| Apr 11, 2024 | reported EPS | FY2025 | $13.40 – $13.70 | New |
| Apr 11, 2024 | Free cash flow | FY2025 | $1.40B – $1.50B | New |
| Apr 11, 2024 | Enterprise operating income growth: reported | FY2025 | +10% – +12% | New |
| Apr 11, 2024 | Enterprise operating income growth: comparable | FY2025 | +8% – +10% | New |
| Apr 11, 2024 | Weighted average diluted shares outstanding | FY2025 | 183 | New |
| Apr 11, 2024 | Tax rate | FY2025 | 18.5% | New |
| Apr 11, 2024 | Interest expense | FY2025 | $445.00M – $455.00M | New |
| Apr 11, 2024 | Operating cash flow | FY2025 | $2.80B – $3.00B | New |
| Apr 11, 2024 | Enterprise net sales growth | FY2025 | +6% – +7% | New |
| Jan 5, 2024 | Capital expenditures | FY2024 | $1.20B – $1.30B | Reaffirmed |
| Jan 5, 2024 | comparable EPS outlook , excluding Canopy EIE | FY2024 | $12.00 – $12.20 | Reaffirmed |
| Jan 5, 2024 | reported EPS outlook | FY2024 | $9.15 – $9.35 | Lowered |
| Jan 5, 2024 | Free cash flow | FY2024 | $1.40B – $1.50B | Raised |
| Jan 5, 2024 | Operating cash flow | FY2024 | $2.60B – $2.80B | Raised |
| Oct 5, 2023 | Capital expenditures | FY2024 | $1.20B – $1.30B | New |
| Oct 5, 2023 | comparable EPS | FY2024 | $12.00 – $12.20 | Raised |
| Oct 5, 2023 | reported EPS | FY2024 | $9.60 – $9.80 | Raised |
| Oct 5, 2023 | free cash flow | FY2024 | $1.20B – $1.30B | Reaffirmed |
| Oct 5, 2023 | operating cash flow | FY2024 | $2.40B – $2.60B | New |
| Jun 30, 2023 | Capital expenditures | FY2024 | $1.20B – $1.30B | Reaffirmed |
| Jun 30, 2023 | comparable EPS | FY2024 | $11.70 – $12.00 | Reaffirmed |
| Jun 30, 2023 | reported EPS | FY2024 | $9.35 – $9.65 | Lowered |
| Jun 30, 2023 | free cash flow | FY2024 | $1.20B – $1.30B | Reaffirmed |
| Jun 30, 2023 | operating cash flow | FY2024 | $2.40B – $2.60B | Reaffirmed |
| Apr 6, 2023 | Capital expenditures | FY2024 | $1.20B – $1.30B | New |
| Apr 6, 2023 | comparable EPS | FY2024 | $11.70 – $12.00 | New |
| Apr 6, 2023 | reported EPS | FY2024 | $11.60 – $11.90 | New |
| Apr 6, 2023 | free cash flow | FY2024 | $1.20B – $1.30B | New |
| Apr 6, 2023 | operating cash flow | FY2024 | $2.40B – $2.60B | New |
| Jan 5, 2023 | Capital expenditures | FY2023 | $1.10B – $1.20B | Lowered |
| Jan 5, 2023 | comparable basis EPS | FY2023 | $11.00 – $11.20 | Lowered |
| Jan 5, 2023 | reported basis EPS | FY2023 | $0.15 – $0.35 | Lowered |
| Jan 5, 2023 | free cash flow | FY2023 | $1.50B – $1.60B | Raised |
| Jan 5, 2023 | operating cash flow | FY2023 | $2.60B – $2.80B | Reaffirmed |
| Oct 6, 2022 | Capital expenditures | FY2023 | $1.30B – $1.40B | Reaffirmed |
| Oct 6, 2022 | comparable basis EPS | FY2023 | $11.20 – $11.60 | Raised |
| Oct 6, 2022 | reported basis EPS | FY2023 | $0.75 – $1.15 | Lowered |
| Oct 6, 2022 | Free cash flow | FY2023 | $1.30B – $1.40B | Reaffirmed |
| Oct 6, 2022 | operating income growth | FY2023 | +3% – +5% | New |
| Oct 6, 2022 | Weighted average diluted shares outstanding | FY2023 | 186.5 | New |
| Oct 6, 2022 | Tax rate: reported | FY2023 | 71% | New |
| Oct 6, 2022 | comparable excluding Canopy equity earnings impact | FY2023 | 20% | New |
| Oct 6, 2022 | Interest expense | FY2023 | $360.00M – $370.00M | New |
| Oct 6, 2022 | Operating cash flow | FY2023 | $2.60B – $2.80B | Reaffirmed |
| Oct 6, 2022 | net sales growth | FY2023 | +8% – +10% | New |
| Oct 6, 2022 | net sales decline | FY2023 | 0% – +2% | Lowered |
| Apr 7, 2022 | Capital expenditures | FY2023 | $1.30B – $1.40B | New |
| Apr 7, 2022 | comparable basis EPS | FY2023 | $11.20 – $11.50 | New |
| Apr 7, 2022 | reported basis EPS | FY2023 | $11.15 – $11.45 | New |
| Apr 7, 2022 | free cash flow | FY2023 | $1.30B – $1.40B | New |
| Apr 7, 2022 | operating cash flow | FY2023 | $2.60B – $2.80B | New |
| Jan 6, 2022 | Capital expenditures | FY2022 | $1.00B – $1.10B | New |
| Jan 6, 2022 | comparable basis EPS | FY2022 | $10.50 – $10.65 | New |
| Jan 6, 2022 | reported basis EPS | FY2022 | -$0.25 – -$0.10 | New |
| Jan 6, 2022 | free cash flow | FY2022 | $1.40B – $1.50B | New |
| Jan 6, 2022 | operating cash flow | FY2022 | $2.40B – $2.60B | New |
Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.
Press releases
Releases Constellation Brands filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- Results
- Update
- Results
- Update
- Update
- Update
- Results
- Update
- Results
- Update
- Results
- Update
- Update
- Results